S 8334 requires health insurance plans to cover all recommended doses of the COVID-19 vaccine (SARS-CoV-2), adding it to a list of mandatory immunizations already covered by New York insurance law. This affects insurance companies, healthcare providers, and patients by mandating reimbursement for the vaccine without cost-sharing. The bill amends multiple sections of New York’s insurance and social services laws to include "severe acute respiratory syndrome coronavirus 2" in required coverage, aligning with federal standards for biological products. It applies to all insurance contracts effective January 1 after the law takes effect.
Provides that the commissioner of education may promulgate rules and regulations for a health education curriculum to include menstrual disorders, including but not limited to, endometriosis.
Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Requires that services at addiction treatment centers operated by the office of addiction services and supports shall not be refused at such centers if a person is unable to pay.
Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Requires anti-bias training for every medical student, medical resident and physician assistant student in the state; requires the department of health to make an annual report on the implementation and effectiveness of such training.
Requires health insurance for state officers and employees who receive health insurance benefits from the state to take effect immediately upon employment.
Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.